Becky Bates

1.1k total citations
16 papers, 664 citations indexed

About

Becky Bates is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Surgery. According to data from OpenAlex, Becky Bates has authored 16 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 6 papers in Critical Care and Intensive Care Medicine and 3 papers in Surgery. Recurrent topics in Becky Bates's work include Sepsis Diagnosis and Treatment (14 papers), Pneumonia and Respiratory Infections (3 papers) and Hemodynamic Monitoring and Therapy (3 papers). Becky Bates is often cited by papers focused on Sepsis Diagnosis and Treatment (14 papers), Pneumonia and Respiratory Infections (3 papers) and Hemodynamic Monitoring and Therapy (3 papers). Becky Bates collaborates with scholars based in United States, Belgium and South Africa. Becky Bates's co-authors include Howard Levy, Pierre‐François Laterre, Richard G. Wunderink, Sachin Yende, David E. Joyce, Rebecca L. Qualy, Mark D. Williams, Dennis G. Maki, Gary Garber and Gary T. Kinasewitz and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Critical Care Medicine.

In The Last Decade

Becky Bates

15 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Becky Bates United States 10 478 210 161 103 81 16 664
Joël Cousson France 14 430 0.9× 226 1.1× 133 0.8× 59 0.6× 98 1.2× 22 710
Ronan Boulmé France 9 543 1.1× 340 1.6× 245 1.5× 51 0.5× 74 0.9× 17 951
A. Sicignano Italy 7 572 1.2× 354 1.7× 94 0.6× 54 0.5× 101 1.2× 16 834
Rébecca Hamidfar-Roy France 13 335 0.7× 148 0.7× 234 1.5× 51 0.5× 193 2.4× 20 834
James M. Horton United States 9 460 1.0× 191 0.9× 59 0.4× 85 0.8× 54 0.7× 11 620
Jos F. Frencken Netherlands 16 528 1.1× 210 1.0× 110 0.7× 73 0.7× 58 0.7× 19 878
Jason Ferreira United States 16 206 0.4× 110 0.5× 119 0.7× 124 1.2× 103 1.3× 39 598
Gisela De La Rosa Colombia 13 493 1.0× 201 1.0× 92 0.6× 29 0.3× 99 1.2× 25 902
Travis Jones United States 10 427 0.9× 136 0.6× 102 0.6× 68 0.7× 35 0.4× 22 675
Marcel Hochreiter Germany 13 553 1.2× 348 1.7× 69 0.4× 86 0.8× 90 1.1× 24 768

Countries citing papers authored by Becky Bates

Since Specialization
Citations

This map shows the geographic impact of Becky Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becky Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becky Bates more than expected).

Fields of papers citing papers by Becky Bates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Becky Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becky Bates. The network helps show where Becky Bates may publish in the future.

Co-authorship network of co-authors of Becky Bates

This figure shows the co-authorship network connecting the top 25 collaborators of Becky Bates. A scholar is included among the top collaborators of Becky Bates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Becky Bates. Becky Bates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Richards, Guy A., Howard Levy, Pierre‐François Laterre, et al.. (2011). CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS. Journal of Intensive Care Medicine. 26(1). 34–40. 66 indexed citations
2.
Wheeler, Arthur P., Jay S. Steingrub, Gregory A. Schmidt, et al.. (2008). A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial*. Critical Care Medicine. 36(1). 14–23. 25 indexed citations
3.
Richards, Guy A., Howard Levy, Pierre‐François Laterre, et al.. (2007). CURB-65 PNEUMONIA SEVERITY INDEX AND APACHE II SCORES TO ASSESS MORTALITY RISK IN COMMUNITY-ACQUIRED PNEUMONIA PATIENTS FROM PROWESS. CHEST Journal. 132(4). 559A–559A. 1 indexed citations
4.
Laterre, Pierre‐François, Gary Garber, Howard Levy, et al.. (2005). Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*. Critical Care Medicine. 33(5). 952–961. 132 indexed citations
5.
Booth, Frank V. McL., Mary B. Short, Andrew F. Shorr, et al.. (2005). Application of a population-based severity scoring system to individual patients results in frequent misclassification. Critical Care. 9(5). R522–9. 26 indexed citations
6.
Levy, Howard, Pierre‐François Laterre, Becky Bates, & Rebecca L. Qualy. (2005). Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated). Critical Care. 9(5). R502–7. 14 indexed citations
7.
Levy, Howard, et al.. (2005). Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated). 9(5). 1 indexed citations
8.
Fry, Donald E., Gregory J. Beilman, Sara B. Johnson, et al.. (2004). Safety of Drotrecogin Alfa (Activated) in Surgical Patients with Severe Sepsis. Surgical Infections. 5(3). 253–259. 15 indexed citations
9.
Lowry, Stephen F., Samir S. Awad, Henri R. Ford, et al.. (2004). Static and Dynamic Assessment of Biomarkers in Surgical Patients with Severe Sepsis. Surgical Infections. 5(3). 261–268. 7 indexed citations
10.
Barie, Philip S., Mark D. Williams, Jill Shwed McCollam, et al.. (2004). Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. The American Journal of Surgery. 188(3). 212–220. 63 indexed citations
11.
Bates, Becky, et al.. (2004). Enterprise-based HIV/AIDS strategies: Integration through organisational architecture. South African Journal of Business Management. 35(3). 13–22.
12.
Linde‐Zwirble, Walter T., et al.. (2004). RESOURCE USE VARIATION AMONG SEVERE SEPSIS PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN THE XEUS STUDY. Critical Care Medicine. 32(Supplement). A69–A69. 1 indexed citations
13.
Steingrub, Jay S., Michael L. Cheatham, Karen Safcsak, et al.. (2004). IMPROVED OUTCOMES IN CLOSED VERSUS OPEN MEDICAL ICUS AMONG SEVERE SEPSIS PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED). Critical Care Medicine. 32(Supplement). A145–A145. 1 indexed citations
14.
Dhainaut, Jean-François, Pierre-François Laterre, Steven P. LaRosa, et al.. (2003). The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*. Critical Care Medicine. 31(9). 2291–2301. 69 indexed citations
15.
Ely, E. Wesley, et al.. (2003). Drotrecogin Alfa (Activated) Treatment of Older Patients with Severe Sepsis. Clinical Infectious Diseases. 37(2). 187–195. 61 indexed citations
16.
Wunderink, Richard G., Sachin Yende, Pierre‐François Laterre, et al.. (2003). Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni. CHEST Journal. 124(4). 91S–91S. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joël Cousson Breakdown of academic impact, for papers by Ronan Boulmé Breakdown of academic impact, for papers by A. Sicignano Breakdown of academic impact, for papers by Rébecca Hamidfar-Roy Breakdown of academic impact, for papers by James M. Horton Breakdown of academic impact, for papers by Jos F. Frencken Breakdown of academic impact, for papers by Jason Ferreira Breakdown of academic impact, for papers by Gisela De La Rosa Breakdown of academic impact, for papers by Travis Jones Breakdown of academic impact, for papers by Marcel Hochreiter
Rankless by CCL
2026